| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.23 | 5e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.24 | 6e-05 |